Topical Ruxolitinib for Immune Checkpoint Inhibitor–Induced Vitiligo
The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Monika Fida (ORCID: https://orcid.org/0000-0001-8026-8995)
- Barbara Melotti (ORCID: https://orcid.org/0000-0003-1041-391X)
- Ina Sotiri
- Emi DIKA
- Federico Venturi
Institutions
- Mother Teresa Hospital (AL)
- Azienda USL di Bologna (IT)
- University of Bologna (IT)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1111/ijd.70367
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00